Bowen Li

School Of Bioengineering & Key Laboratory Of Protein Modification And Disease
Dalian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

MZF1 (Myeloid Zinc Finger 1) activates transcriptional activity of p53 and suppresses breast cancer cell proliferation via acetyltransferase PCAF (P300/CBP associated factor).

MZF1 (Myeloid Zinc Finger 1) activates transcriptional activity of p53 and suppresses breast cancer cell proliferation via acetyltransferase PCAF (P300/CBP associated factor).

Journal: Genes & diseases

Published: August 05, 2022

DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9.

DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9.

Journal: Cell death discovery

Published: September 02, 2021

FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.

FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.

Journal: Cancer letters

Published: October 06, 2020

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

Journal: NPJ precision oncology

Published: July 02, 2020

Associations between TNFSF4 gene polymorphisms (rs2205960 G > A, rs704840 T > G and rs844648 G > A) and susceptibility to autoimmune diseases in Asians: a meta-analysis.

Associations between TNFSF4 gene polymorphisms (rs2205960 G > A, rs704840 T > G and rs844648 G > A) and susceptibility to autoimmune diseases in Asians: a meta-analysis.

Journal: Immunological investigations

Published: March 27, 2020

TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9.

TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9.

Journal: Cancer cell international

Published: February 21, 2020

SUMOylation of MCL1 protein enhances its stability by regulating the ubiquitin-proteasome pathway.

SUMOylation of MCL1 protein enhances its stability by regulating the ubiquitin-proteasome pathway.

Journal: Cellular signalling

Published: February 07, 2020

Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase9 expression.

Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase9 expression.

Journal: Cancer cell international

Published: March 31, 2019

Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.

Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.

Journal: Disease markers

Published: March 09, 2019

Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.

Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.

Journal: Cell death & disease

Published: January 30, 2018

α-catenin SUMOylation increases IκBα stability and inhibits breast cancer progression.

α-catenin SUMOylation increases IκBα stability and inhibits breast cancer progression.

Journal: Oncogenesis

Published: November 08, 2017

SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.

SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.

Journal: Oncotarget

Published: August 14, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026